Zhu-Ying Yan

Zhu-Ying Yan

Auto-generated profile, based on publicly available information

Zhu-Ying Yan

Analysis and Testing Center

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RHRong Huang
Rong Huang
CHChun-Hua Huang
Chun-Hua Huang
JCJing Chen
Jing Chen
ZYZhu-Ying Yan
Zhu-Ying Yan
MTMiao Tang
Miao Tang
BZBen-Zhan Zhu
Ben-Zhan Zhu
Mitochondrial DNA (mtDNA) is known to play a critical role in cellular functions. However, the fluorescent probe enantio-selectively targeting live-cell mtDNA is rare. We recently found that the well-known DNA ‘light-switch’ [Ru(phen)2dppz]Cl2 can image nuclear DNA in live-cells with chlorophenolic counter-anions via forming lipophilic ion-pairing complex. Interestingly, after washing with fresh-medium, [Ru(phen)2dppz]Cl2 was found to re-localize from nucleus to mitochondria via ABC transporter proteins. Intriguingly, the two enantiomers of [Ru(phen)2dppz]Cl2 were found to bind enantio-selectively with mtDNA in live-cells not only by super-resolution optical microscopy techniques (SIM, STED), but also by biochemical methods (mitochondrial membrane staining with Tomo20-dronpa). Using [Ru(phen)2dppz]Cl2 as the new mtDNA probe, we further found that each mitochondrion containing 1–8 mtDNA molecules are distributed throughout the entire mitochondrial matrix, and there are more nucleoids near nucleus. More interestingly, we found enantio-selective apoptotic cell death was induced by the two enantiomers by prolonged visible light irradiation, and in-situ self-monitoring apoptosis process can be achieved by using the unique ‘photo-triggered nuclear translocation’ property of the Ru complex. This is the first report on enantio-selective targeting and super-resolution imaging of live-cell mtDNA by a chiral Ru complex via formation and dissociation of ion-pairing complex with suitable counter-anions.

18 October 2024 in Analytical Chemistry
Verified
Journal Article
Closed access
SLShi-Lun Li
Shi-Lun Li
ZYZhu-Ying Yan
Zhu-Ying Yan
HQHai-Long Qian
Hai-Long Qian
SXShu-Ting Xu
Shu-Ting Xu
XYXiu-Ping Yan
Xiu-Ping Yan

20 March 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
XCXi-Juan Chao
Xi-Juan Chao
CHChun-Hua Huang
Chun-Hua Huang
MTMiao Tang
Miao Tang
ZYZhu-Ying Yan
Zhu-Ying Yan
RHRong Huang
Rong Huang
BZBen-Zhan Zhu
Ben-Zhan Zhu
Targeted and enantioselective delivery of chiral diagnostic-probes and therapeutics into specific compartments inside cells is of utmost importance in the improvement of disease detection and treatment. The classical DNA ‘light-switch’ ruthenium(II)-polypyridyl complex, [Ru(DIP)2(dppz)]Cl2 (DIP = 4,7-diphenyl-1,10-phenanthroline, dppz = dipyridophenazine) has been shown to be accumulated only in the cytoplasm and membrane, but excluded from its intended nuclear DNA target. In this study, the cationic [Ru(DIP)2(dppz)]2+ is found to be redirected into live-cell nucleus in the presence of lipophilic 3,5-dichlorophenolate or flufenamate counter-anions via ion-pairing mechanism, while maintaining its original DNA recognition characteristics. Interestingly and unexpectedly, further studies show that only the Δ-enantiomer is selectively translocated into nucleus while the Λ-enantiomer remains trapped in cytoplasm, which is found to be mainly due to their differential enantioselective binding affinities with cytoplasmic proteins and nuclear DNA. More importantly, only the nucleus-relocalized Δ-enantiomer can induce obvious DNA damage and cell apoptosis upon prolonged visible-light irradiation. Thus, the use of Δ-enantiomer can significantly reduce the dosage needed for maximal treatment effect. This represents the first report of enantioselective targeting and photosensitization of classical Ru(II) complex via simple ion-pairing with suitable weak acid counter-anions, which opens new opportunities for more effective enantioselective cancer treatment.

1 August 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ZYZhu-Ying Yan
Zhu-Ying Yan
JCJing Chen
Jing Chen
JSJie Shao
Jie Shao
ZJZe-Qing Jiao
Ze-Qing Jiao
TTTian-Shu Tang
Tian-Shu Tang
BZBen-Zhan Zhu
Ben-Zhan Zhu


5 October 2025 in Analytical Chemistry
Verified
Journal Article
Closed access
ZYZhu-Ying Yan
Zhu-Ying Yan
LYLong Yuan
Long Yuan
FHFang Hao
Fang Hao
XYXiu-Ping Yan
Xiu-Ping Yan